Cystic Fibrosis is typically diagnosed through a combination of genetic testing, sweat chloride tests, and clinical evaluation. Genetic testing can identify specific mutations in the CFTR gene, confirming the diagnosis. The sweat chloride test measures the concentration of chloride in sweat, which is abnormally high in individuals with CF. Newborn screening programs also commonly test for CFTR mutations.
